• In the News

    April 5, 2016
    Intarcia Appoints Anthony Hurley as VP, Global Commercial Manufacturing and Operations, Reporting to Chairman & CEO Kurt Graves

    Read more

  • Message from the CEO

    Intarcia Speaks Out at 34th JP Morgan Healthcare Conference Calling for “Sanity” Instead of a Reliance on Current Models Failing to Control T2D In Most Patients

    With impressive clinical results and business milestones to report, Kurt Graves explained the need to unleash disruptive innovation so that real progress can be achieved in T2D.

    Read more

  • Chairman & CEO Kurt Graves Explains the Vision and Culture of Intarcia

    What immediately sets Intarcia apart from other companies is what’s most visible – our product candidate that is built on amazing technology and chemistry. But what most outsiders cannot see is even more amazing – our people and our culture. Our people have a will to win. They are not intimidated by the skeptics who doubt that a relatively small biotech can change the course of treatment in serious disease. They say, "Watch us!"

    Hear Kurt Graves speak on this topic ›